BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22896754)

  • 1. "But Dr. Old, we already have an antibody!" Reflections on Lloyd Old's "academic biotech" approach for targeted antibodies.
    Ritter G
    Cancer Immun; 2012; 12():9. PubMed ID: 22896754
    [No Abstract]   [Full Text] [Related]  

  • 2. The genealogy of SEREX.
    Pfreundschuh M
    Cancer Immun; 2012; 12():7. PubMed ID: 22896752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Monoclonal antibodies and cancer].
    López González JS; Selman Lama M
    Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoclonal antibody therapy for cancer.
    Lovett DR; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1991; 12():147-63. PubMed ID: 1931442
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoclonal antibody-based design of antitumor drugs: prerequisites and progress].
    Chmutin EF; Ivanov PK; Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 2004; (12):10-6. PubMed ID: 15678682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting highlights: 5th Annual International Congress on Monoclonal Antibodies in Cancer, August 2005, Quebec City, Canada.
    Reddy GK
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):71-6. PubMed ID: 16231842
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibody therapy for central nervous system lymphomas: an emerging treatment paradigm.
    Wong ET
    Expert Opin Pharmacother; 2005 Jun; 6(7):1107-14. PubMed ID: 15957965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotoxin therapy of malignancy.
    Grossbard ML; Nadler LM
    Important Adv Oncol; 1992; ():111-35. PubMed ID: 1582669
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibody therapy: a literature review].
    Del Debbio CB; Tonon LM; Secoli SR
    Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous typing: a tedious but orthodox approach for defining human tumor antigens with clarity.
    Shiku H; Takahashi T
    Cancer Immun; 2012; 12():3. PubMed ID: 22896748
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of monoclonal antibodies to tumor diagnosis and therapy.
    Rosen ST; Winter JN; Epstein AL
    Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
    Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
    Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibodies in the treatment of cancer.
    Dillman RO
    Crit Rev Oncol Hematol; 1984; 1(4):357-85. PubMed ID: 6397268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization effect of monoclonal antibodies against tumor-associated antigens during cancer treatment.
    Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
    Ann N Y Acad Sci; 1993 Aug; 690():337-9. PubMed ID: 8368748
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on monoclonal antibody therapy in chronic lymphocytic leukemia.
    Zent CS; Kay NE
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):107-13. PubMed ID: 16163170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
    Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
    Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radioimmunolocalization is a new aid used in the diagnosis of tumors].
    Lakartidningen; 1988 Nov; 85(46):3969. PubMed ID: 3185065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.